Physician

Alejandro Gonzalez Campos, M.D

According to 2025 Medicare claims, Alejandro Campos, M.D (NPI: 1508130543) practices endocrinology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is VALLEY DIABETES & ENDOCRINOLOGY COMPREHENSIVE CENTER P.L.L.C. (NPI: 1376109637; TIN: 834284327) and primary practice location at 78504-3288.

Campos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 152 traditional Medicare patients, billed 9,080 HCPCS/CPT codes, and received $139,782 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,454 prescription claims across 634 beneficiaries totaling $2,658,445 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 113 claims. Open Payments data shows 166 records totaling $63,840. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,742 to $139,782. Similarly, Part D prescription costs have risen steadily, from $91,816 to $2,658,445. In contrast, DME billing represents a smaller volume and rose steadily, from $186 to $32,013.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	116	175	$11,742
2017	238	622	$43,868
2018	253	721	$50,694
2019	233	582	$41,872
2020	151	604	$46,656
2021	138	622	$48,478
2022	134	1,034	$50,038
2023	162	4,278	$87,515
2024	152	9,080	$139,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	89	408	$91,816
2016	206	793	$284,419
2017	350	2,903	$1,339,687
2018	421	3,569	$1,923,808
2019	493	4,132	$2,640,271
2020	373	3,739	$2,479,677
2021	393	3,963	$2,798,302
2022	452	3,205	$2,401,459
2023	526	3,273	$2,833,854
2024	634	3,454	$2,658,445

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	45	89	$1,257
2018	54	111	$1,691
2019	53	153	$11,570
2020	44	162	$22,233
2021	59	224	$28,841
2022	40	220	$38,533
2023	18	160	$30,082
2024	18	113	$26,871

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	60	$114
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	23	23	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	132	350	$87
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	48	111	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	82	154	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	499	19,270	$695,608
Ozempic	Semaglutide	301	12,694	$400,923
Evenity (2 Syringes)	Romosozumab-Aqqg	63	2,002	$146,985
Jardiance	Empagliflozin	109	6,881	$129,850
Synjardy Xr	Empagliflozin/Metformin Hcl	102	6,480	$115,946

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	18	66	$26,202
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	32	$633
A4259	Lancets, per box of 100	N	N/R	15	$36

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	166	$63,840	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandro Gonzalez Campos, M.D?

Tedicare shows public-source Medicare data for Alejandro Gonzalez Campos, M.D (NPI 1508130543), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandro Gonzalez Campos, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alejandro Gonzalez Campos, M.D?

Alejandro Gonzalez Campos, M.D is linked to VALLEY DIABETES & ENDOCRINOLOGY COMPREHENSIVE CENTER P.L.L.C. (billing NPI 1376109637) in the available physician profile data.

Does Alejandro Gonzalez Campos, M.D have Open Payments data?

Alejandro Gonzalez Campos, M.D has 166 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.